These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7870892)

  • 21. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.
    Merlo Pich E; Samanin R
    Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
    Shepherd JK; Grewal SS; Fletcher A; Bill DJ; Dourish CT
    Psychopharmacology (Berl); 1994 Sep; 116(1):56-64. PubMed ID: 7862931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze.
    File SE
    Psychopharmacology (Berl); 1990; 100(2):281-2. PubMed ID: 1968279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors triggering abolishment of benzodiazepines effects in the Four-Plate Test--retest in mice.
    Petit-Demoulière B; Hascoët M; Bourin M
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):41-7. PubMed ID: 17544259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam.
    Fernandes C; Arnot MI; Irvine EE; Bateson AN; Martin IL; File SE
    Psychopharmacology (Berl); 1999 Aug; 145(3):251-9. PubMed ID: 10494573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMDA and D1 receptors are involved in one-trial tolerance to the anxiolytic-like effects of diazepam in the elevated plus maze test in rats.
    Zhou H; Yu CL; Wang LP; Yang YX; Mao RR; Zhou QX; Xu L
    Pharmacol Biochem Behav; 2015 Aug; 135():40-5. PubMed ID: 26004015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine.
    Lin HQ; Burden PM; Christie MJ; Johnston GA
    Pharmacol Biochem Behav; 1999 Mar; 62(3):403-8. PubMed ID: 10080230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.
    Horváth K; Andrási F; Botka P; Hámori T
    Acta Physiol Hung; 1992; 79(2):153-61. PubMed ID: 1363928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests.
    Chaouloff F; Durand M; Mormède P
    Behav Brain Res; 1997 Apr; 85(1):27-35. PubMed ID: 9095339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice.
    Vargas KM; Da Cunha C; Andreatini R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1394-402. PubMed ID: 16828217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The elevated plus-maze is not sensitive to the effect of stressor controllability in rats.
    Grahn RE; Kalman BA; Brennan FX; Watkins LR; Maier SF
    Pharmacol Biochem Behav; 1995 Nov; 52(3):565-70. PubMed ID: 8545475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A lack of tolerance to the anxiolytic effects of diazepam on the plus-maze: comparison of male and female rats.
    Stock H; Foradori C; Ford K; Wilson MA
    Psychopharmacology (Berl); 2000 Jan; 147(4):362-70. PubMed ID: 10672629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest.
    Roy V; Chapillon P; Jeljeli M; Caston J; Belzung C
    Psychopharmacology (Berl); 2009 Mar; 203(1):131-41. PubMed ID: 18998112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.
    Rodgers RJ; Cole JC; Aboualfa K; Stephenson LH
    Pharmacol Biochem Behav; 1995 Dec; 52(4):805-13. PubMed ID: 8587923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task.
    Ennaceur A; Michalikova S; van Rensburg R; Chazot PL
    Behav Brain Res; 2008 Mar; 188(1):136-53. PubMed ID: 18055029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.
    Rodgers RJ; Shepherd JK
    Psychopharmacology (Berl); 1993; 113(2):237-42. PubMed ID: 7855188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.
    Calzavara MB; Patti CL; Lopez GB; Abílio VC; Silva RH; Frussa-Filho R
    Life Sci; 2005 Mar; 76(19):2235-46. PubMed ID: 15733938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs.
    Thompson BL; Rosen JB
    Neuropharmacology; 2006 Jan; 50(1):57-68. PubMed ID: 16185722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.
    Ouagazzal AM; Kenny PJ; File SE
    Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.